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ABSTRACT
The eukaryotic polypyrimidine tract binding protein (PTB) serves primarily as a
regulatorofalternativesplicingofmessengerRNA,butisalsoco-optedtootherroles
such as RNA localisation and translation initiation from internal ribosome entry
sites.TheneuronalparalogueofPTB(nPTB)is75%identicalinaminoacidsequence
with PTB. Although the two proteins have broadly similar RNA binding specificities
and effects on RNA splicing, differential expression of PTB and nPTB can lead to
the generation of alternatively spliced mRNAs. RNA binding by PTB and nPTB is
mediated by four RNA recognition motifs (RRMs). We present here the crystal and
solution structures of the C-terminal domain of nPTB (nPTB34) which contains
RRMs3and4.Asexpectedthestructuresaresimilartoeachotherandtothesolution
structureoftheequivalentfragmentfromPTB(PTB34).Theresultconfirmsthat,as
foundforPTB,RRMs3and4ofnPTBinteractwithoneanothertoformastableunit
that presents the RNA-binding surfaces of the component RRMs on opposite sides
that face away from each other. The major differences between PTB34 and nPTB34
arise from amino acid side chain substitutions on the exposed β-sheet surfaces and
adjoiningloopsofeachRRM,whicharelikelytomodulateinteractionswithRNA.
Subjects Biochemistry, Biophysics, Molecular Biology, Virology
Keywords Polypyrimidine tract binding protein, Protein crystallography, Nuclear magnetic
resonance spectroscopy, Pre-mRNA splicing, RNA binding proteins, Protein structure
INTRODUCTION
Alternative splicing is the rule rather than the exception in the human genome. Over
95% of multi-exon genes produce alternatively spliced mRNAs (Nilsen & Graveley, 2010),
yielding many more protein variants or isoforms than specified by the number of genes.
Theprocessofalternativesplicingiscontrolledbyregulatorysequenceswithinpre-mRNA
transcriptsthatrecruitsuitesofproteinstodeterminewhetherselectedexonsareincluded
orexcludedasmRNAisbroughttomaturity.
The polypyrimidine tract binding protein (PTB) is a well-characterized regulator of
alternativesplicing(Garc´ ıa-Blanco,Jamison&Sharp,1989;Giletal.,1991)althoughitalso
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(reviewedbySawickaetal.,2008).PTBdoesnotrecognizeauniqueRNAsequence;rather
it is specific for short motifs (e.g., UCUCU, UCUU) within pyrimidine rich regions of
pre-mRNA (Singh, Valc´ arcel & Green, 1995; P´ erez et al., 1997). In alternative splicing, PTB
binding is most commonly associated with exclusion or skipping of the regulated exon,
although more recent genome-wide splicing studies have indicated that PTB binding can
also promote exon inclusion in a minority of cases (Xue et al., 2009; Llorian et al., 2010;
Witten&Ule,2011).
Three tissue-specific homologues of PTB have been identified—smPTB, ROD1 and
nPTB—allofwhichhavehighlevelsofaminoacidsequenceidentitywiththeprototypical
protein (69–74%) and are therefore likely to have very similar structures. smPTB (smooth
muscle tissue) has so far only been found in rodents (Gooding, Kemp & Smith, 2003),
whereasthehomologueROD1isexpressedprimarilyinhematopoietictissues(Yamamoto
et al., 1999). nPTB is found predominantly in brain and testis but also, at low levels, in
musclecells(Markovtsovetal.,2000;Polydoridesetal.,2000).
PTB and nPTB bind to the same RNA sequences and have similar effects on alternative
splicing events for a number of transcripts (Markovtsov et al., 2000; Pilipenko et al., 2001;
Spellman,Llorian&Smith,2007).However,forsomeneuronal-specificalternativesplicing
eventstheexpressionofnPTBleadstodistinctoutcomes.Forexample,thetyrosinekinase
c-src has an n-src isoform found only in brain tissue that requires nPTB for the selective
inclusion of a neuronal-specific exon (Markovtsov et al., 2000; Sharma, Falick & Black,
2005;Boutzetal.,2007).
PTB(anditshomologues)contain4RNArecognitionmotifdomains(RRMs)separated
by long flexible linkers and arrayed, when not bound to RNA, in a relatively extended,
linear conformation (Petoukhov et al., 2006). The solution structures of each RRM have
been solved in the absence (Conte et al., 2000; Simpson et al., 2004; Vitali et al., 2006) and
presence(Oberstrassetal.,2005)ofRNA.WhileRRMs1and4adoptacanonicalβαββαβ
topology with two helices packed against a four-strand β-sheet that forms the primary
RNA binding surface, RRMs 2 and 3 have a modified architecture. In these domains a
C-terminalextensionbeyondβ4loopsacrosstheupperedgeoftheβ-sheetandaddsafifth
strandonthefarsideofthesheet;thisexpandsthesizeoftheRNAbindingplatform,while
the β4-β5 loop provides additional points of interaction with RNA (Conte et al., 2000;
Simpsonetal.,2004;Oberstrassetal.,2005).
The α-helical regions of RRMs 3 and 4 pack together to form a stable unit in which
the RNA-binding β-sheets are exposed on opposite sides; it has been proposed that
this configuration enforces looping of RNA that plays an important role in defining
exon structures to be excised from pre-mRNA (Oberstrass et al., 2005; Vitali et al., 2006;
Lamichhane et al., 2010). Although early studies had suggested that RRM3 and RRM4
might not interact at physiological salt concentrations (Conte et al., 2000; Clerte & Hall,
2006), it is now generally accepted that this pair of RRMs have fixed relative orientations
(Lamichhaneetal.,2010;Maynard&Hall,2010).EvidencesuggeststhatRRM1andRRM2
bind RNA as individual domains although RRM2 is also involved in protein–protein
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 2/18interactions with the splicing co-regulator Raver1 (Rideau et al., 2006). Crystallographic
analysis has revealed how the helical face of the PTB RRM2 provides a binding surface for
specificrecognitionofspecificpeptidemotifsinRaver1(Joshietal.,2011).
Although PTB and nPTB are likely to have similar structures because of their high
sequence identity (75%) (Fig. 1A), to begin to tease out the structural basis for observed
differences in splicing regulation we have determined the structure of a C-terminal
fragment of nPTB that contains RRMs 3 and 4 (nPTB34). We have solved the structures
both crystallographically and by NMR. Here we compare those structures with each other
andwiththesolutionstructureoftheequivalentfragmentfromPTBisoform1(calledhere
PTB34).
RESULTS AND DISCUSSION
Crystal structure of nPTB34
nPTB34, a C-terminal nPTB fragment that contains RRMs 3 and 4 (residues 336-531)
was over-expressed in E. coli, purified and crystallized by sitting drop vapor diffusion
in 20% PEG 6000, 0.1 Tris pH 8.0 with 2 mM ZnCl2 as an additive (see Materials and
Methods).ThecrystalsdiffractedX-raysto1.7 ˚ Aandwerefoundtobelongtospace-group
P1. Attempts to phase the diffraction data by molecular replacement using the solution
structure of PTB34 (Vitali et al., 2006) were unsuccessful. Instead, phases were obtained
by multi-wavelength anomalous dispersion (MAD) using data collected from a crystal of
Se-Met-labeled nPTB34. This produced a high-quality electron density map that revealed
a total of eight nPTB34 molecules in the asymmetric unit (Fig. 1B). The eight polypeptide
chains were built almost in their entirety; due to poor electron density residue 336 at the
start of nPTB34 was omitted, as were residues 420-423 (and one or two flanking residues
in some chains) at the C-terminal end of the β4-β5 loop of RRM3. The final model,
which incorporates 788 water molecules, was refined to an Rfree of 20.8% with good
stereochemistry(Fig.1C).FulldatacollectionandrefinementstatisticsaregiveninTable1.
Thestructuresof the eightcopiesofnPTB34within theasymmetricunitofourcrystals
are very similar to one another (Fig. 1D). Pairwise superpositions of the eight chains give
an average root-mean-square deviation (RMSD) for Cα atoms of only 0.17 ˚ A. This is not
surprising since the unit cell parameters deviate only marginally from a P21212 space
group(seeMaterialsandMethods);whatthismeansisthatthereareonlytwopositionsin
the asymmetric unit,exemplified by chains A, B, E andF on the one hand andC, D, G and
Hontheother,thathavesignificantlydifferentpackingenvironments.
There are a total of 12 Zn2+ ions associated with each asymmetric unit which mediate
crystal contacts between nPTB34 molecules involving variously His 412, His 491 and
His 520. In each case the required tetrahedral coordination appears to be completed
by Cl− ions and/or water molecules. These zinc-mediated interactions explain why the
cation is required to obtain crystals (see Materials and Methods) but, since only two of
the four ligands are provided by amino acids from nPTB34, they are not considered to be
physiologicallysignificant.
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 3/18Figure1 CrystalstructureofnPTB34.(A)DomainstructureofnPTB.Residuenumbersfordomainboundariesaregivenalongthetop;percentages
below indicate the sequence identity with PTB within each defined domain or linker region. (B) 3Fo–2Fc electron density map contoured at 1σ for
the refined crystal structure of nPTB34 (shown in stick representation). Carbon atoms in RRM3, RRM4 and the inter-domain linker are coloured
pink, light-blue and grey respectively, a colour-scheme that is maintained throughout for nPTB34; nitrogen and oxygen atoms are coloured blue
and red respectively. (C) The overall fold of the crystal structure of nPTB34 showing secondary structure features. (D) Alignment of all eight chains
within the crystal asymmetric unit. View rotated with respect to panel C showing good overall alignment of secondary structure elements but
differences in the linker.
NMR structure of nPTB34
The solution NMR structure of nPTB34 was obtained from a construct containing
residues 325–531 and is very similar to the one used for crystallography (see Materials
andMethods).Usingatotalof3622nOe-deriveddistancerestraintsand55hydrogenbond
restraints identified from slow exchanging amides we derived a fairly good ensemble of
nPTB34 conformations in solution with a heavy atom RMSD of 0.71 ˚ A of the structured
region (Fig. 2A; Table 2). None of the restraints were violated by more than 0.3 ˚ A and
67% of backbone torsions of the structured residues lay in the most favored region
defined by the Ramachandran plot. Due to signal overlaps and broad linewidths the
β2-β3-loops of both RRMs, the β4-β5 loop RRM3 and part of the second beta strand
in RRM3 could not be completely assigned. Missing assignments in β2 of RRM3
appear to be the reason for the slightly different packing of the first alpha helix (α1) in
RRM3againsttheβ-sheetcomparedtothecrystalstructure.Sinceα1ispartofthedomain
interface this different packing results also in a slight difference in the domain interface
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 4/18Table1 DatacollectionandrefinementstatisticsforthecrystalstructureofnPTB34.
Space-group P1 P21
Datacollection
a, b, c (˚ A) 61.00, 65.81, 99.58 65.81, 60.95, 99.55
α, β, γ (◦) 89.99, 90.00, 89.99 90.00, 90.01, 90.00
Peak Inflection Remote
Wavelength (˚ A) 0.9795 0.9808 0.9813 0.9790
Resolution range (˚ A) 44.74–1.69
(1.72–1.69)
55.10–2.30
(2.42–2.30)
55.14–2.30
(2.42–2.30)
55.27–2.50
(2.64–2.50)
No. of independent reflections 153732 (7340) - - -
Multiplicitya 1.9 (1.9) 1.7 (1.6) 1.7 (1.7) 1.7 (1.7)
Completeness (%) 89.0 (85.6) 89.9 (84.8) 95.9 (96.1) 95.7 (93.5)
I/σI 5.0 (1.1) 10.0 (4.3) 8.7 (3.0) 8.1 (2.4)
Rmerge (%)b 9.6 (70.7) 6.7 (21.2) 8.6 (37.9) 9.4 (47.8)
Modelrefinement 40.81–1.69 ˚ A
No. of non-hydrogen
atoms/waters
12397
Rwork (%)c 17.00
Rfree (%)d 20.76
RMS bonds (˚ A)e 0.006
RMS bond angles (◦) 0.937
Ramachandran plot
(% favoured/allowed)
97.4/1.9
PDB Identifier 4cq1
Notes.
a Values for highest resolution shell given in parentheses.
b Rmerge = 100×Σhkl|Ij(hkl)−⟨Ij(hkl)⟩|/ΣhklΣjI(hkl), where Ij(hkl) and ⟨Ij(hkl)⟩ are the intensity of measurement j
and the mean intensity for the reflection with indices hkl, respectively.
c Rwork = 100×Σhkl||Fobs|−|Fcalc||/Σhkl|Fobs|.
d Rfree is the Rwork calculated using a randomly selected 5% sample of reflection data that were omitted from the
refinement.
e RMSD, root-mean-squared deviations.
compared to the nPTB34 crystal structure and RNA bound and free PTB34 solution
structures.
Comparison of crystal and NMR structures of nPTB34
Overall there is very good correspondence between the structures of nPTB34 determined
crystallographically and by NMR. Superposition of the two models using just Cα atoms
gives an RMSD of 3.0 ˚ A, and RMSDs of 1.8 and 2.6 ˚ A for RRMs 3 and 4 respectively (Fig.
2B). These values are slightly higher than for the superposition of the crystal structure
of nPTB34 onto the solution structures of PTB34 in the absence or presence of RNA,
which both give overall RMSDs of 1.3 ˚ A (Fig. 2C). This largely reflects the fact that the
solution structure of nPTB34 (unlike PTB34 (Vitali et al., 2006)) was determined without
the aid of segmental labeling and thus chemical shift completeness for protons of only
77% could be achieved. The relative orientation of RRMs 3 and 4 differs slightly between
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 5/18Figure 2 Solution structure of nPTB34 and comparison with related structures. (A) Ensemble of the 20 lowest energy solution structures of
nPTB34 shown as Cα traces coloured by domain. (B) Ribbon representation of the superposition of the crystal structure of nPTB34 (coloured by
domain) on the nPTB34 solution structure (yellow) denoted by ‘PX’ and ‘NMR’ labels respectively. (C) Superposition of the crystal structure of
nPTB34 (coloured by domain) on the solution structure of PTB34 (PDB ID 2evz; orange) (Vitali et al., 2006). (D) Superposition of the crystal
structure of nPTB34 (coloured by domain) on the crystal structure of the equivalent domain from hnRNP-L (PDB ID 3 to 8; green) (Zhang et al.,
2013). (E) Close up of the superposition shown in panel D to illustrate the similarities and differences in the linker regions between RRMs 3 and 4
in nPTB34 and hnRNP-L.
the crystal and solution structures of nPTB34 but this is unlikely to be significant since
there is no significant difference in the domain orientations between the crystal structure
of nPTB34 and the solution structure of PTB34 (see below); moreover superposition of
the crystal structures of the PTB34 fragments from nPTB and hnRNP-L (Zhang et al.,
2013) (RMSD = 1.3 ˚ A) shows that the relative disposition of RRM3 and RRM4 is highly
conservedbetweenthesetwoproteins(Fig.2D).
Within each RRM of nPTB34 there is good correspondence of secondary structure
features between the crystal and solution structures. Those loops in the crystal structure
with the highest temperature factors (RRM3: β2-β3 and the C-terminal end of β4-β5;
RRM4: β1-α2, β2-β3, α2-β4; and the inter-domain linker) are those exhibiting greatest
mobility in the solution structure (Figs. 2A and 2B). Notably, the β4-β5 loop is not
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 6/18Table2 StatisticsforthesolutionstructureofnPTB34.
Number of distance restraints 3677
Intraresidual 657
Sequential (|i−j| = 1) 941
Medium range (1 < |i−j| < 5) 684
Long range (|i−j| ≥ 5) 134
Hydrogen bondsa 55
Energy statisticsb
Average distance constraint violations (˚ A)
0.1–0.2 ˚ A 52.4 ± 4.2
0.2–0.3 ˚ A 0.4 ± 0.6
>0.3 ˚ A 0.0 ± 0.0
Maximal (˚ A) 0.20 ± 0.03
Mean AMBER distance violation energy (kcal mol−1) 100.9 ± 2.5
Mean AMBER energy (kcal mol−1) −6170.0 ± 15.5
Mean deviation from ideal covalent geometry
Bond length (˚ A) 0.0042 ± 0.0000
Bond angle (degrees) 1.796 ± 0.007
Ramachandran plot statisticsb,c,d
Most favoured regions (%) 67.1 ± 2.0
Additionally allowed regions (%) 29.2 ± 1.9
Generously allowed regions (%) 3.5 ± 0.8
Disallowed regions (%) 0.1 ± 0.2
RMS deviations from mean structure Statisticsb,c
Backbone atoms (˚ A) 0.37 ± 0.05
Heavy atoms (˚ A) 0.71 ± 0.05
PDB identifier 2mju
Notes.
a Hydrogen bond constraints were identified from slow exchanging amide protons in D2O.
b Statistics computed for the deposited bundle of 20 violation energy best structures selected out of 30 energy best
structures refined in Amber (Pearlman et al., 1995).
c Based on structured residue range as defined by cyana command overlay: 9–47, 52–86, 91–113, 126–163, 168–207.
d Ramachandran plot, as defined by the Procheck (Laskowski et al., 1996).
disorderedinthecrystalstructureofRRM2butthismaysimplybebecauseitisinvolvedin
morecrystalcontacts(Joshietal.,2011).
Within the inter-domain linker (residues 433–453), the central portion (residues
439–448) exhibits considerable conformational variation in the solution structure of
nPTB34 (Fig. 2A). A similar but slightly smaller region (residues 443–449), which
protrudes away from the body of the domain, is variable between the eight chains present
in the asymmetric unit of the nPTB34 crystals (Fig. 1D). Again, this likely reflects packing
variations since there are effectively only two distinct conformers evident for residues
443–449,whichpartitionintothetwodistinctpackingenvironmentsofthepseudoP21212
space group (see above). The N- and C-terminal portions of the linker are involved in a
number of specific polar and nonpolar interactions that help to stabilize the packing of
RRM3andRRM4andaredescribedinmoredetailbelow.
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 7/18Figure 3 Comparison of the inter-domain interface within nPTB34 with the PTB RRM2-Raver1 interaction. (A) The inter-domain interface in
the crystal structure of nPTB34. RRM3 is shown with pink backbone and side-chain carbon atoms along with a semi-transparent rendering of its
molecular surface (light-grey). The portion of RRM4 that contacts RRM3 within nPTB34 is shown without its molecular surface. The oxygen atoms
of bound water molecules located in the crystal structure are indicated by red spheres. (B) Superposition of the nPTB34 crystal structure (coloured
as in panel A) with the structure of the PTB RRM2-Raver1 complex (PDB ID 3zzy; RRM2—green; Raver1—yellow) (Joshi et al., 2011). Selected side
chains are indicated. (C) The interaction between PTB RRM2 (green) and Raver1 (yellow). As for RRM3 in panel A, the molecular surface of RRM2
is indicated by a semi-transparent rendering.
Comparison of nPTB34 with PTB34
PTB and nPTB have 75% sequence identity overall but this is focused in the RRMs where
the sequence identity between equivalent domains ranges from 80% (RRMs 3 and 4) to
88% (RRM2) (Fig. 1A). As expected, the three-dimensional structures of nPTB34 and
PTB34 are very similar; differences are largely confined to the local effects of amino acid
substitutions.
The crystal structure of nPTB34 reveals that the interaction between RRM3 and RRM4
is stabilized by the exclusion of water molecules, which allows direct contact between a
conserved set of hydrophobic residues—Ile 505, Leu 508, Ile 509 and Phe 526 from RRM4
and the apolar portions of Ser 354, Thr 357, Leu 358, Val 361 and Met 400 from RRM3
(Fig. 3A). Ringing this hydrophobic core are direct and water-mediated hydrogen bonds
betweentheRRMsandfromtheRRMstothelinkerpolypeptide.WithintheRRM3-RRM4
interfacethereareonlyfiveaminoacidchangesbetweenPTB34andnPTB34andtheseare
generally of a conservative character; the apolar residues Ile 356, Met 400 and Val 505 in
PTB34 are replaced by Thr 357, Leu 399 and Ile 505 respectively in nPTB34, while His 397
and His 400 in PTB34 are altered to Gln 398 and Tyr 401 (Table 3). The water-mediated
hydrogenbondinteractionfromTyr401ofRRM3tothesidechainofAsp510inRRM4of
nPTB34isthereforelostinPTB34butneitherthisnortheotheraminoacidchangesappear
sufficienttosignificantlyaltertheinteractionbetweenthetwodomains.Asimilardegreeof
conservationoftheapolarresiduesatthehydrophobicinterfacebetweenRRM3andRRM4
is also seen in hnRNP-L (Zhang et al., 2013) (Table 3). The relative orientation of these
domains is therefore a conserved feature of PTB, nPTB and hnRNP-L. The incorporation
of a pair of His residues within the inter-domain interface of PTB34 (H397, H400) may
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 8/18Table 3 Conservation of amino acids within the interface between RRM3-RRM4 in PTB, nPTB and
hnRNP-L.
PTB nPTB hnRNP-L
S353 S354 R398
I356 T357 N401
L357 L358 V402
V360 V361 L405
Y361 Y362 Y406
H397 Q398 N442
L399 M400 M444
RRM3
H400 Y401 F445
V501 V501 K552
V505 I505 L556
L508 L508 L559
I509 I509 G560
RRM4
F526 F526 F582
affectthestabilityofthemodule atlowpH(Nordlundetal.,2003),butwearenot awareof
anycircumstanceswherepHregulationoftheconformationwouldbeapplied.
Although the interaction of RRM4 with the helical face of RRM3 within PTB34 and
nPTB34 is much more extensive than the interaction of PTB-binding peptides in Raver1
with the equivalent face of RRM2 (Joshi et al., 2011), there is one interesting parallel.
SuperpositionoftheRRM2-raver1co-crystalstructureontoRRM3ofnPTB34revealsthat
the Raver1 peptide occupies essentially the same position as helix α2 of RRM4 (Figs. 3B
and 3C). Although the Raver1 peptide is non-helical—in fact it has a pinched but largely
extended conformation—it inserts a pair of Leu residues (Leu 500 and Leu 501 in PDB
entry3zzy)intoahydrophobicpocketformedbetweenthehelicesα1andα2ofRRM2that
effectively mimics the positioning of Ile 505 and Ile 509 from RRM4 into the equivalent
pocketonRRM3withinnPTB34.
Although the RRMs are the most highly conserved features between PTB and nPTB,
therearesomenotabledifferencesontheirRNAbindingsurfaces.Thesedifferencesappear
tobemoreconcentratedonRRM3.Whilethereareatotaloffiveaminoacidsubstitutions
in nPTB RRM3 of residues identified to contact RNA in the solution structure of the
complexofPTB34withaCUCUCUoligonucleotide(Oberstrassetal.,2005),thereareonly
twosuchaminoacidchangesinRRM4(Fig.4).
ThereplacementofPhe371intheβ2-β3loopofRRM3inPTB34byTyr372innPTB34
is conservative and likely to preserve the stacking interaction with the cytosine base at
position 5 in CUCUCU RNA oligomer. However, the substitution of Asn 376 (to Ser 377)
at the start of the β3 strand and a triplet of replacements in the β4-β5 loop (Asn 413,
Gln 421 and Glu 422 in PTB34 to Thr 414, Leu 422 and Asp 423 respectively in nPTB34)
may modulate RNA binding (Fig. 4A). Likewise the β2-β3 loop of RRM4 in PTB34 is
altered in nPTB34 by deletion of Lys 489 and replacement of Arg 491 by His, a pair of
changes that may also alter RNA interactions (Fig. 4B). The idea that these structural
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 9/18Figure 4 Location of amino acid differences on the RNA binding surfaces of PTB34 and nPTB34. (A)
Superposition of the solution structure of RRM3 from PTB34 in complex with a hexameric CUCUCU
RNA oligomer (PDB ID 2adc; grey) (Oberstrass et al., 2005) onto RRM3 from the crystal structure of
nPTB34 (this work; pink). The disordered portion of the β4-β5 loop in RRM3 of nPTB34 is indicated by
a dashed line. The side chains of amino acids that differ between the two structures (discussed in the text)
are labeled to indicate the change from PTB34 to nPTB34 and shown for the solution structure of the
PTB34-RNA complex. The structural difference in loop β2-β3 between the two structures shown most
likely reflects conformational variability in this region in the absence of RNA. (B) Superposition of the
solutionstructureofRRM4withthehexamericCUCUCURNAoligomerfrom(PDBID2adc;grey)with
RRM4 from the nPTB34 crystal structure (this work; light-blue). To avoid cluttering the figure only the
fourRNAnucleotidesthatmakecontactwithRRM4areshown.Thesidechainsofaminoacidsthatdiffer
between the two structures are shown for the substitution R491H and the deletion of Lys 489 (PTB34) in
nPTB34, which is labeled K491Δ.
changes affect RNA affinity is supported by mutagenesis experiments which showed
that residues in the β2-β3 loops of RRMs 3 and 4 and in the β4-β5 loop of RRMs are
important for RNA binding (Conte et al., 2000; Yuan et al., 2002). The observed amino
acid changes are likely to contribute to the differences observed in the interactions of
PTB and nPTB with larger RNA targets (Pilipenko et al., 2001). However, it should not be
forgotten that sequence differences between PTB and nPTB are focused in regions outside
the RRM domains and these may well also be important for differences in splicing activity
(Markovtsov et al., 2000; Robinson & Smith, 2005), perhaps by recruiting different protein
cofactors.
MATERIALS AND METHODS
Plasmid construction and protein expression and purification of
nPTB34 for crystal structure determination
The cDNA coding for residues 336–531 of nPTB were amplified by PCR and ligated
into the E. coli expression vector pETM-11 (Zou et al., 2003), which adds an N-terminal
hexahistidine tag that could be removed using the Tobacco Etch Virus N1a protease. The
fragment was cloned to position the first residue (G336) as the Gly in the TEV protease
Joshi et al. (2014), PeerJ, DOI 10.7717/peerj.305 10/18recognition site (ENLYFQ/G); protease processing therefore removed all vector-derived
aminoacids.
ExpressionofnPTB34wasinducedinE. coliBL21(DE3)cellsat37◦Cforfourhoursby
additionof1mMisopropylβ-D-1-thiogalactopyranoside(IPTG).Cellswereresuspended
in 0.1 M NaCl, 25 mM Tris HCl pH7.5, 0.1% Triton X-100, 0.5 mM phenylmethylsulfonyl
fluoride (PMSF) and 1 mg/ml lysozyme and lysed by sonication. Cell debris and nucleic
acid were removed by centrifugation at 25000 g for 40 min at 4◦C in the presence of
1 mg/ml protamine sulfate. nPTB34 was purified from the supernatant by gravity flow
through TALON Metal Affinity Resin (Clontech) with stepped elution. The hexahistadine
tag was cleaved by addition of 1 mg Tobacco Etch Virus N1a protease for 20 mg of
nPTB34 and dialysed overnight into 50 mM Tris pH7.8, containing 0.1 M NaCl, 10%
glycerol, 3 mM β-mercaptoethanol and 0.5 µM ethylenediamine tetraacetic acid (EDTA).
Cleaved nPTB34 was purified away from the tag, uncleaved nPTB34 and N1a protease
by a second application to TALON resin. Proteins were further purified by size exclusion
chromatographyonaSuperdex75(GEHealthcare)usingan ¨ AKTAFPLCsystemin25mM
Tris pH 7.8, 0.1 M NaCl and 0.5 mM DTT. Peak fractions were concentrated and stored
at −80◦C. Expression of Se-Methionine (Se-Met) labeled nPTB34 was performed as
above with the following differences: proteins were expressed in E. coli B834 (DE3) cells
in minimal media supplemented with Se-Met (Molecular Dimensions). Purification
proceeded as for unlabeled protein with the addition of 5 mM β-mercaptoethanol to
all buffers. Incorporation of Se-Met was determined to be 100% by MALDI-TOF mass
spectrometry(datanotshown).
Crystal structure determination of nPTB34
Purified recombinant nPTB34 was concentrated to ≈5 mg/ml in 100 mM NaCl,
20 mM Tris (pH 7.8) and 0.5 mM DTT. nPTB34 was crystallised by sitting drop vapor
diffusion with a reservoir solution containing 0.1 M Tris (pH 8.0), 2 mM ZnCl2 and 20%
polyethylene glycol (PEG) 6000. Crystals appeared at first as stacked plates, but single
crystals were obtained after micro-seeding into equilibrated drops of nPTB34 in 0.1 M
Tris (pH 8.0), 2 mM ZnCl2 and 12% PEG 6000. No crystals were obtained in the absence
of ZnCl2—the structure revealed that this is because two crystal–packing interactions are
mediated by zinc ions (see Results and Discussion). Crystals were harvested and briefly
incubated in mother liquor supplemented with 20% glycerol before flash cooling in
liquidN2.
X-ray diffraction data were collected from a single crystal (60 µm × 40 µm × 20 µm) at
beamline I02 at the Diamond Light Source (Didcot, UK). Diffraction data were initially
indexed in iMosflm and scaled in space group P21212 using SCALA (Collaborative
Computer Project No. 4, 1994) (RRID:nif-0000-30238). Closer inspection of the data
in POINTLESS suggested the space group was more likely to be P21. At this stage
molecular replacement was attempted in PHASER (McCoy et al., 2007) using the solution
structure of nPTB34 as a search model to locate the four molecules in the asymmetric
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−3 but failed to find any
acceptablesolutions.
We therefore switched to phasing by multi-wavelength anomalous dispersion (MAD)
using isomorphous crystals grown from Se-Met labeled nPTB34 (see above). Diffraction
data were collected at three wavelengths at beamline I03 at the Diamond Light Source
and processed in space-group P21. Heavy atom site were identified using SHELXD within
autoSHARP (Bricogne et al., 2003; Vonrhein et al., 2007; Sheldrick, 2008) and following
density modification the figure of merit was 0.802. Initial model building was performed
automatically in BUCCANEER (Cowtan, 2006) where two nPTB34 molecules were built
in the asymmetric unit. We used this initial model in Phaser 2.1 to find the remaining
pair of molecules in the asymmetric unit. However, maps calculated using the ‘completed’
model remained noisy in the region corresponding to this second pair of polypeptide
chains and refinement stalled at an Rfree value of over 37%. At this stage the data were
re-indexed in P1 and a molecular replacement search performed using the tetrameric
arrangementofcrystallographicmodelsgeneratedasdescribedabovewasusedtolocateall
eight copies of nPTB34 in the larger asymmetric unit. This model was adjusted manually
in COOT (Emsley & Cowtan, 2004) and refined without any further difficulty. Initially,
strict NCS restraints were employed during refinement in CNS v1.2 (Brunger et al., 1998).
TLS refinement and latter cycles of refinement were performed in Phenix without NCS
restraints (Adams et al., 2010), yielding an Rfree of 27.3%. At this stage the structure was
deposited in the Protein Data Bank (PDB; RRID:nif-0000-00135) under ID 4cko, the
manuscript published as a preprint (Joshi et al., 2014) and submitted for peer review.
One reviewer, noting the relatively high value of Rfree, raised the possibility that the
crystals might be twinned, something we had overlooked while resolving the problems
due to the initial mis-assignment of the space-group. Analysis using the xtriage function
inPHENIXrevealedthepresenceoftwinningoperatorsaroundeachofthethreeprincipal
axes. Re-refinement in REFMAC (Winn, Murshudov & Papiz, 2003) (with the presence of
4 twin domains with the following twin operators and fractions: h, k, l −0.153; −h, −k,
l −0.245; h, −k, −l −0.176; −h, k, −l −0.425) significantly reduced the values of Rwork
and Rfree (to 17.0% and 20.8% respectively) but did not appreciably improve the electron
density map, which was already of high quality. Stereochemistry and clashes were assessed
using MolProbity (Adams et al., 2010). The final refined coordinates and structure factors
havebeendepositedwiththePDB(ID4cq1).
Plasmid construction, expression and purification of nPTB34 for
solution structure
A 207-residue C-terminal fragment (residues 325–531) of human nPTB (Swissprot
Q9UKA9), which contain the third and fourth RRMs, was sub-cloned into a pET-28a(+)
vector, using the restriction sites Nde I and Not I. The sequence contained an N-terminal
hexahistidine tag. The proteins were over-expressed in BL21(+) E. coli cultures grown
in M9 minimal medium containing 50 µg/ml Kanamycin. The expression was induced
by IPTG at an OD of 0.4. For 15N-labelling 15N–NH4Cl was added as the only nitrogen
source and for 13C-labelling normal glucose was replaced by 13C labeled glucose. The
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300 mM NaCl, 50 mM NaH2PO4 and 1 mM imidazole at pH8 and lysed by 3 passages
through a cell-cracker (EmulsiFlex-C5 High Pressure Homogenizer; Avestin, Canada).
The protein was purified by two successive Ni-NTA columns (1 ml Ni-NTA resin per liter
of culture). Elution occurred between 40 mM and 200 mM imidazole. After the second
column the protein was dialyzed against the NMR buffer containing 20 mM NaCl and
10 mM NaH2PO4 at pH 5.8 and concentrated by centricon ultra centrifugation to 1 to
2 mM. The purity of the protein sample was checked by SDS PAGE. The final yield per
liter of culture was estimated to be around 20 mg protein. Mass spectroscopy was used to
characterizetheproteins.
NMR spectroscopy
Shigemi NMR tubes with 250 µl sample solution (10% or 100% D2O) were used. NMR
spectra were acquired at 303 K on a Bruker DRX-600 and a Avance-900 spectrometer.
NMRdatawereprocessedusingTopspin3.0(Bruker)andanalyzedusingSparky(Goddard
&Kneller,2007).
For the sequence specific backbone assignment HNCA, HN(CO)CA, CBCA(CO)NH,
HNCACB, 15N HSQC, 13C HSQC as well as 15N TROSY spectra were recorded. The
aliphaticsidechainswereassignedbasedona 15NNOESYanda 13CNOESYwiththehelp
of a 15N TOCSY and a HCCH-TOCSY. The assignment of side chain amides was achieved
byanalyzingthe 15NNOESYandthe 15NHSQC,whilefortheassignmentofthearomatic
side chains a 2D TOCSY and a 2D NOESY in D2O were recorded. Distance restraints used
instructurecalculationswereextractedfrom 15N-NOESY-HSQCand 13C-NOESY-HSQC
in H2O and 2D NOESY in D2O. Hydrogen-bonded NH groups were identified by the
presence of amide resonances in 15N HSQC spectra, which were recorded immediately
afterlyophilizinganddissolvingthesampleinD2O.
NMR structure calculation
Initial peak picking and nOe assignments were performed using the ATNOSCANDID
package (Herrmann, Guntert & Wuthrich, 2002a; Herrmann, Guntert & Wuthrich, 2002b).
Peak lists of the final seventh cycle were used as an input for the program CYANA 3.0
(Guntert, 2004). The “noeassign” protocol of CYANA was used to reassign and calibrate
thenOesignalsofthegivenpeaklists.Theselistsweremanuallyreviewedandthedistance
restraint list were further used by CYANA to calculated 250 structures by a simulated
annealing protocol (20000 MD steps). Based on the target function the 50 best structures
wereselectedforrefinementusingasimulatedannealingprotocolwiththeAMBER9suite
(Pearlman et al., 1995) and against the ff99 force field (Lindorff-Larsen et al., 2010) using
implicit water (Bashford & Case, 2000). The 20 final conformers were selected using a
combined AMBER energy and violation energy as selection criteria. The coordinates have
been deposited in the Protein Data Bank (ID 2mju); NMR chemical shifts and distance
constraints used in the structure calculation have been deposited under ID 19737 to the
BiologicalMagneticResonanceDataBank(BMRB;RRID:nif-0000-21058).
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